A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency (VICARES)

NCT03311269 PHASE2 TERMINATED Results posted

VICARES is a prospective randomized, controlled, multi-center, double blind study treating venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.

Details

Lead sponsor	Vascular Insights, LLC
Phase	PHASE2
Status	TERMINATED
Enrolment	19
Start date	Fri Sep 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Venous Insufficiency

Interventions

• ClariVein RES
• Sodium Tetradecyl Sulfate 1% Injection
• Sodium Tetradecyl Sulfate 3% Injection

Countries

United States